The UK’s medicines regulator has authorised GSK’s Nucala (mepolizumab) as an add-on maintenance treatment for adults with uncontrolled chronic...
Read MoreBial has introduced a new sublingual formulation of apomorphine in the United Kingdom, providing an additional “rescue” treatment option...
Read MoreUS-based premium pet nutrition brand Nulo has officially entered the United Kingdom market, calling the move an important “milestone”...
Read MoreGenfit has announced encouraging preliminary findings from a phase 1b clinical trial evaluating its investigational therapy, GNS561, in combination...
Read MoreFinnish biotechnology company NADMED has announced the launch of the NADMED Award 2026, positioning it as a catalyst for...
Read MoreTitle21 Health Solutions, a portfolio company specialising in life science regulatory support, has joined the Blood and Cells Advocacy...
Read More